161 related articles for article (PubMed ID: 36661195)
1. Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset.
Storelli L; Pagani E; Pantano P; Piervincenzi C; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
J Magn Reson Imaging; 2023 Oct; 58(4):1221-1231. PubMed ID: 36661195
[TBL] [Abstract][Full Text] [Related]
2. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
[TBL] [Abstract][Full Text] [Related]
3. SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.
Battaglini M; Jenkinson M; De Stefano N;
Hum Brain Mapp; 2018 Mar; 39(3):1063-1077. PubMed ID: 29222814
[TBL] [Abstract][Full Text] [Related]
4. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.
Steenwijk MD; Amiri H; Schoonheim MM; de Sitter A; Barkhof F; Pouwels PJW; Vrenken H
Neuroimage Clin; 2017; 15():843-853. PubMed ID: 28794970
[TBL] [Abstract][Full Text] [Related]
5. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
6. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
Xiang B; Wen J; Cross AH; Yablonskiy DA
J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
[TBL] [Abstract][Full Text] [Related]
7. Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis.
Pagani E; Storelli L; Pantano P; Petsas N; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
J Neurol; 2023 Jan; 270(1):446-459. PubMed ID: 36152049
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Intra- and Interscanner Reliability of MRI Protocols for Spinal Cord Gray Matter and Total Cross-Sectional Area Measurements.
Papinutto N; Henry RG
J Magn Reson Imaging; 2019 Apr; 49(4):1078-1090. PubMed ID: 30198209
[TBL] [Abstract][Full Text] [Related]
9. Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects.
Weeda MM; Middelkoop SM; Steenwijk MD; Daams M; Amiri H; Brouwer I; Killestein J; Uitdehaag BMJ; Dekker I; Lukas C; Bellenberg B; Barkhof F; Pouwels PJW; Vrenken H
Neuroimage Clin; 2019; 24():101962. PubMed ID: 31416017
[TBL] [Abstract][Full Text] [Related]
10. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Popescu V; Schoonheim MM; Versteeg A; Chaturvedi N; Jonker M; Xavier de Menezes R; Gallindo Garre F; Uitdehaag BM; Barkhof F; Vrenken H
PLoS One; 2016; 11(1):e0143942. PubMed ID: 26745873
[TBL] [Abstract][Full Text] [Related]
11. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.
Opfer R; Krüger J; Spies L; Hamann M; Wicki CA; Kitzler HH; Gocke C; Silva D; Schippling S
Neuroimage Clin; 2020; 28():102478. PubMed ID: 33269702
[TBL] [Abstract][Full Text] [Related]
13. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
[TBL] [Abstract][Full Text] [Related]
14. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
15. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
[TBL] [Abstract][Full Text] [Related]
16. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
[TBL] [Abstract][Full Text] [Related]
17. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Thalamic Atrophy in MS: From the Multicenter Italian Neuroimaging Network Initiative Data Set to Clinical Application.
Storelli L; Pagani E; Pantano P; Gallo A; De Stefano N; Rocca MA; Filippi M;
AJNR Am J Neuroradiol; 2023 Dec; 44(12):1399-1404. PubMed ID: 38050001
[TBL] [Abstract][Full Text] [Related]
19. Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses.
van Nederpelt DR; Amiri H; Brouwer I; Noteboom S; Mokkink LB; Barkhof F; Vrenken H; Kuijer JPA
Neuroradiology; 2023 Oct; 65(10):1459-1472. PubMed ID: 37526657
[TBL] [Abstract][Full Text] [Related]
20. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
